Trial intelligence / Profile preview

Effect of Food and Rabeprazole on the Pharmacokinetics of HMPL-760 in Healthy Participants

NCT07643272Phase 1Completed

Sponsor
HUTCHMED
Start
Jun 2026
Primary completion
Jul 2026
Countries
1
01

Overview

Phase 1, randomised, open-label trial of HMPL-760 (4 arms), sponsored by HUTCHMED. Primary endpoints: Area Under the Curve from Time Zero to the Last Quantifiable Concentration, Area Under the Curve from Time Zero to Infinity and 1 more. Started Jun 2026; status: completed.

02

Drugs

HMPL-760

Beyond the preview

Go deeper on NCT07643272.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07643272.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call